Experts are carefully examining retatrutide, a novel drug showing considerable potential in assisting individuals struggle with excess body size. This twin-effect substance, acting as both a incretin receptor site agonist and a glucose-dependent agonist, appears to influence appetite and enhance metabolic function , leading to substantial body los